Journal Information
Vol. 99. Issue 3.
Pages 213-216 (April 2008)
Share
Share
Download PDF
More article options
Vol. 99. Issue 3.
Pages 213-216 (April 2008)
Case report
Full text access
B-Cell Pseudolymphoma Caused by Aluminium Hydroxide Following Hyposensitization Therapy
Pseudolinfoma B Inducido Por Hidróxido de Aluminio Tras Tratamiento Hiposensibilizante
Visits
5871
I. Hernándeza, O. Sanmartínb,
Corresponding author
osanmartinj@medynet.com

Correspondence: Servicio de Dermatología, Instituto Valenciano de Oncología, C/ Profesor Beltrán Báguena, 8, 46009 Valencia, Spain.
, C. Cardác, S. Gómezc, A. Alfarob
a Servicio de Dermatología, Hospital General Básico de la Defensa de Valencia, Spain
b Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain
c Servicio de Anatomía Patológica, Hospital Clínico de Valencia, Spain
This item has received
Article information
Abstract

Aluminium hydroxide is used as an adjuvant in vaccines. We describe the case of a patient who presented a persistent adverse local reaction to aluminium hydroxide due to hyposensitization therapy to dust mites. Multiple painful and pruriginous subcutaneous nodules were observed in both arms, along with hypertrichosis at the injection site. Histology revealed a pseudolymphomatous B cell reaction predominantly involving cells that were CD20 positive, did not express BCL-2, and did not display the t(14;18) translocation. The cells also exhibited polyclonal rearrangement of the immunoglobulin heavy chains. X-ray spectral microanalysis revealed deposits of inorganic aluminium in the granular histiocytes among the germinal centers. The patient was diagnosed with cutaneous B-cell pseudolymphoma due to aluminium hydroxide as a result of immunotherapy.

Key words:
B-cell pseudolymphoma
aluminium hydroxide
subcutaneous nodules
Resumen

El hidróxido de aluminio es una sustancia que se utiliza como adyuvante de las vacunas. Describimos el caso de una paciente que presenta una reacción adversa local y persistente a esta sustancia debido al tratamiento hiposensibilizante frente a los ácaros. Clínicamente se observan múltiples nódulos subcutáneos en ambos brazos, dolorosos, pruriginosos y con hipertricosis en el sitio de la inyección. El estudio histológico muestra una reacción pseudolinfomatosa de tipo B con predominio de células CD20 positivas, bcl-2 y t(14-18) negativos y una policlonalidad de los genes de cadenas pesadas de las inmunoglobulinas. El microanálisis de espectro de rayos X identificó depósitos inorgánicos de aluminio dentro de los histiocitos granulares entre los centros germinativos. Se establece el diagnóstico de pseudolinfoma B cutáneo por hidróxido de aluminio secundario a una inmunoterapia.

Palabras clave:
pseudolinfoma B
hidróxido de aluminio
nódulos subcutáneos
Full text is only aviable in PDF
References
[1]
G.A. Culora, A.D. Ramsay, J.M. Theaker.
Aluminium and injection site reactions.
J Clin Pathol, 49 (1996), pp. 844-847
[2]
E. Maubec, L. Pinquier, M. Viguier, F. Caux, E. Amsler, S. Aractingi, et al.
Vaccination-induced cutaneous pseudolymphoma.
J Am Acad Dermatol, 52 (2005), pp. 623-629
[3]
K. Kaaber, A.O. Nielsen, N.K. Veien.
Vaccination granulomas and aluminium allergy: course and prognostic factors.
Contact Dermatitis, 26 (1992), pp. 304-306
[4]
L. Frost, P. Johansen, S. Pedersen, N. Veien, P.A. Ostergaard, M.H. Nielsen.
Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts.
Allergy, 40 (1985), pp. 368-372
[5]
M. Vogelbruch, B. Nuss, M. Korner, A. Kapp, P. Kiehl, W. Bohm.
Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations.
Allergy, 55 (2000), pp. 883-887
[6]
J. Lin, J. Zhang, X. Dong, H. Fang, J. Chen, N. Su, et al.
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.
[7]
F.J. Authier, S. Sauvat, C. Christov, P. Chariot, G. Raisbeck, M.F. Poron, et al.
AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background.
Neuromuscul Disord, 16 (2006), pp. 347-352
[8]
V. García-Patos, R.M. Pujol, A. Alomar, A. Cistero, R. Curell, M.T. Fernández-Figueras, et al.
Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts.
Arch Dermatol, 131 (1995), pp. 1421-1424
[9]
E. Bergfors, B. Trollfors, A. Inerot.
Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer.
Vaccine, 22 (2003), pp. 64-69
[10]
G. Burg, W. Kempf, A. Cozzio, J. Feit, R. Willemze, S.J. E, et al.
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
J Cutan Pathol, 32 (2005), pp. 647-674
[11]
H. Chong, K. Brady, D. Metze, E. Calonje.
Persistent nodules at injection sites (aluminium granuloma) – clinicopathological study of 14 cases with a diverse range of histological reaction patterns.
Histopathology, 48 (2006), pp. 182-188
[12]
V. García-Patos, A. Alomar, R. Lleonart, A. Cistero, X. Matías- Guiu.
Subcutaneous nodules and sensitivity to aluminum in patients undergoing hyposensitivity immunotherapy.
Med Cutan Ibero Lat Am, 18 (1990), pp. 83-88
[13]
M. Morroni, G. Barbatelli, V. Carboni, A. Sbarbati, S. Cinti.
Subcutaneous nodules in a patient hyposensitized with aluminium-containing allergen extracts: a microanalytical study.
Anal Cell Pathol, 9 (1995), pp. 235-241
[14]
E. Nagore, J.A. Martínez-Escribano, A. Tato, V. Sabater, J.J. Dilata.
Subcutaneous nodules following treatment with aluminium-containing allergen extracts.
Eur J Dermatol, 11 (2001), pp. 138-140
[15]
O.P. Sangueza, S. Yadav, C.R. White Jr., R.M. Braziel.
Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.
Am J Dermatopathol, 14 (1992), pp. 408-413
[16]
K. Mikasa, D. Watanabe, C. Kondo, Y. Tamada, Y. Matsumoto.
Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma.
J Am Acad Dermatol, 53 (2005), pp. 911-912
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?